Semen Indonesia stock gained 1.32 percent as profit jumped

Published on 10/07/2026 at 00:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Semen Indonesia stock delivered IDR 17.65 trillion in first-half revenue, up 13.1 percent year over year on September 9, 2026. Attributable profit reached IDR 228 billion.

Semen Indonesia, ID1000106800, Illustration mit AI erstellt.

Semen Indonesia stock (ISIN ID1000106800) was last at IDR 1,540 on the Indonesia Stock Exchange on October 6, 2026, up 1.32 percent on the session. The latest reported figures show a sharp profit recovery, but operating margins remain the key test for the next leg of the turnaround.

Half year revenue gains ground

According to ANTARA on September 9, 2026, Semen Indonesia reported first-half 2026 revenue of IDR 17.65 trillion, up 13.1 percent from the same period a year earlier. Total sales volume rose 5.6 percent to 18.28 million tons, with domestic volume increasing 9.7 percent to 14.18 million tons.

The profit comparison was even larger. Net income climbed 445.9 percent year over year to IDR 207 billion, while profit attributable to owners of the parent rose 471 percent to IDR 228 billion, according to ANTARA.

Analyst target still exceeds price

Mirae Asset Sekuritas Indonesia maintained a Buy rating but cut its target to IDR 2,460 from IDR 2,750 in research dated September 14, 2026, as the valuation multiple fell to 3.5 times projected 2026 EV/EBITDA from 4.4 times. Mirae Asset Sekuritas said the revised target reflected stronger results, higher volume and average selling price assumptions, alongside lower interest costs.

The new target lies 59.74 percent above the October 6 price. The same research identified lower sales volume, weaker blended pricing and higher input costs as downside risks, while second-quarter EBITDA fell 0.5 percent year over year to IDR 1.1 trillion.

Stock remains below yearly high

At IDR 1,540, the stock stood 52.76 percent below its 52-week high of IDR 3,260 and above its 52-week low of IDR 1,380 on October 6, 2026. Trading volume reached 11,058,800 shares, while the market capitalization was IDR 10.4 trillion.

The market is therefore weighing two different signals: first-half revenue and volume improved, while margin pressure and valuation discipline continue to limit the recovery case. Semen Indonesia's next performance checkpoint is whether stronger domestic demand can translate into sustained earnings quality rather than a rebound from a low comparison base.